RIPE-KG · Version 1.1.0 · Resource
ripekg:retraction-notice/28371
https://w3id.org/ripe/ripe-kg/retraction-notice/28371
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEA08F1214EC0C80369 |
prov:used |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
ripekg:evaluation/RIPEA1CF9367F3C1B1AFC |
prov:used |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
ripekg:evaluation/RIPEA4A841AC6ADD4DA5B |
prov:used |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
ripekg:evaluation/RIPEAC60164BBD59BB4A3 |
prov:used |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
ripekg:evaluation/RIPEAD590A93EC19D8A75 |
prov:used |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
ripekg:evaluation/RIPEAE59AF25CB9D16527 |
prov:used |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
prism:doi |
10.1093/jn/nxaa342 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
prism:publicationDate |
2020-10-23 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
prism:publicationName |
The Journal of Nutrition |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
dcterms:publisher |
ripekg:publisher/RIPEP071DE88059C4E4B3Oxford Academic |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
dcterms:title |
High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
http://purl.org/spar/cito/retracts |
ripekg:work/10.1093%2Fjn%2Fnxy116 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
rdf:type |
http://purl.org/spar/fabio/RetractionNotice |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
rdf:type |
rdfs:Resource |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
rdf:type |
owl:Thing |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
rdf:type |
ripe:RetractionNoticeRetraction notice |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
rdf:type |
tido:Evidence |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
rdf:type |
tido:PieceOfInformation |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
owl:sameAs |
https://semopenalex.org/work/W3094346325 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
prov:wasAttributedTo |
ripekg:source/retraction-watchRetraction Watch Database |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA08F1214EC0C80369 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA1CF9367F3C1B1AFC |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEA4A841AC6ADD4DA5B |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAC60164BBD59BB4A3 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAD590A93EC19D8A75 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEAE59AF25CB9D16527 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA08F1214EC0C80369 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA1CF9367F3C1B1AFC |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEA4A841AC6ADD4DA5B |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAC60164BBD59BB4A3 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAD590A93EC19D8A75 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAE59AF25CB9D16527 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
ripe:concerns |
ripekg:author/RIPEAU892450EA294F60B3Ebrahim Kouchaki |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
ripe:concerns |
ripekg:author/RIPEAU9FA3E917EB998375Naghmeh Mirhosseini |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
ripe:concerns |
ripekg:work/10.1093%2Fjn%2Fnxy116 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
ripe:rationale |
Concerns/Issues About Data;Investigation by Journal/Publisher;Updated to Retraction |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
ripe:retractionWatchRecordId |
28371 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA08F1214EC0C80369-human-1-3 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA08F1214EC0C80369-inspectai-1-3 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA1CF9367F3C1B1AFC-human-1-3 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA1CF9367F3C1B1AFC-inspectai-1-3 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEA4A841AC6ADD4DA5B-inspectai-1-3 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAC60164BBD59BB4A3-human-1-3 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAC60164BBD59BB4A3-inspectai-1-3 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAD590A93EC19D8A75-human-1-3 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAD590A93EC19D8A75-inspectai-1-3 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAE59AF25CB9D16527-human-1-3 |
ripekg:retraction-notice/28371High-dose ω-3 Fatty Acid Plus Vitamin D3 Supplementation Affects Clinical Symptoms and Metabolic Status of Patients with Multiple Sclerosis: A Randomized Controlled Clinical Trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAE59AF25CB9D16527-inspectai-1-3 |